Zepbound can cause fatigue in some patients. Clinical trial data shows fatigue in approximately 7 to 9 percent of participants at higher doses, compared to about 4 percent on placebo. Tiredness tends to be most pronounced during the first weeks of treatment and during dose increases, and it generally improves with time.

Detailed Explanation

Zepbound is the brand name for tirzepatide approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition. It is a dual GIP/GLP-1 receptor agonist, meaning it targets two incretin hormone pathways simultaneously. This dual mechanism contributes to its strong weight loss results but also means the body undergoes significant metabolic adjustments that can temporarily produce fatigue.

Fatigue Rates in Clinical Trials

In the SURMOUNT-1 trial, which enrolled over 2,500 adults without diabetes, fatigue was reported by approximately 5 percent of patients on the 5 mg dose, 7 percent on the 10 mg dose, and 9 percent on the 15 mg dose, compared to 4 percent on placebo. The dose-response pattern confirms that the medication itself contributes to fatigue. In the SURMOUNT-2 trial for patients with type 2 diabetes, similar trends were observed.

Why Zepbound Causes Fatigue

Zepbound produces substantial appetite reduction, leading to a significant caloric deficit in most patients. Average weight loss in SURMOUNT-1 was approximately 21 percent of body weight at the 15 mg dose over 72 weeks, which represents a major metabolic shift. The body must transition from relying heavily on dietary calories to mobilizing stored fat for energy, and this adaptation period commonly produces tiredness.

The dual GIP/GLP-1 mechanism also delays gastric emptying more effectively than single-pathway drugs, which can change nutrient absorption timing and affect energy availability throughout the day. Combined with reduced overall intake, patients may notice energy dips at times when they would normally eat.

Dose Escalation and Fatigue

Zepbound follows a dose-escalation schedule that starts at 2.5 mg and increases by 2.5 mg every four weeks up to the target dose (5 mg, 10 mg, or 15 mg). Each increase can trigger a temporary return of fatigue as the body adjusts to stronger appetite suppression and metabolic changes. Patients typically report that fatigue is worst during the first week after each dose increase and improves by the third or fourth week at the new dose.

What to Consider

• Eat consistently throughout the day, even in smaller portions, to maintain steady energy levels.
• Focus on protein and complex carbohydrates at each meal to prevent energy crashes.
• Drink water regularly. Dehydration is a common and often overlooked cause of fatigue during GLP-1 therapy.
• Gentle physical activity like walking can improve energy even when you feel tired.
• Let your physician know if fatigue is severe or does not improve after several weeks at a stable dose.
• Your prescriber can adjust the pace of dose escalation if side effects including fatigue are significantly affecting your daily life.

Related Questions

• How long does Zepbound fatigue last?
• Is fatigue worse on Zepbound than on Wegovy?
• Can Zepbound cause extreme tiredness?
• What helps with low energy on Zepbound?

Physician-Supervised Weight Loss Therapy

FormBlends provides tirzepatide therapy with full physician oversight, including side effect monitoring and personalized dosing adjustments. Start with a telehealth consultation to see if Zepbound is right for you.